retatrutide trial results Shows Promising in Type 2 Diabetes and Obesity | Michael Weintraub, MD posted on the topic New Retatrutide Phase 3 Trial

(available at: [Google Scholar] 73.Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson Jet al

Prescriptions were expected to increase further in 2025, with 1,392 written in the years first 5 months

All injections are provided directly at the clinic or can be taken home depending on patient preference

53 In both Phase 1a and 1b trials, it has been established that orforglipron does not have food or water administration restrictions and may provide a safe and effective oral treatment option for patients with T2D and other indications

Oral pill, easier to take

Over time, as new studies are released, additional options for managing side effects may arise